Kantonsspital St.Gallen
login

publications

Jochen Vehoff

title  
 
Cagol A, Schaedelin S, Barakovic M, Benkert P, Todea R A, Rahmanzadeh R, Galbusera R, Lu P J, Weigel M, Melie-Garcia L, Ruberte E, Siebenborn N, Battaglini M, Radue E W, Yaldizli ├, Oechtering J, Sinnecker T, Lorscheider J, Fischer-Barnicol B, M├╝ller S, Achtnichts L, Vehoff J, Disanto G, Findling O, Chan A, Salmen A, Pot C, Bridel C, Zecca C, Derfuss T, Lieb J M, Remonda L, Wagner F, Vargas M I, Du Pasquier R, Lalive P H, Pravat├á E, Weber J, Cattin P C, Gobbi C, Leppert D, Kappos L, Kuhle J, Granziera C. Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis. JAMA Neurol 2022;.
   
Engelter S T, Traenka C, Gensicke H, Schaedelin S A, Luft A R, Simonetti B G, Fischer U, Michel P, Sirimarco G, K├Ągi G, Vehoff J, Nedeltchev K, Kahles T, Kellert L, Rosenbaum S, Von Rennenberg R, Sztajzel R, Leib S L, Jung S, Gralla J, Bruni N, Seiffge D, Feil K, Polymeris A A, Steiner L, Hamann J, Bonati L H, Brehm A, De Marchis G M, Peters N, Stippich C, Nolte C H, Christensen H, Wegener S, Psychogios M N, Arnold M, Lyrer P, TREAT-CAD Investigators . Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial. Lancet Neurol 2021; 20:341-350.
   
De Marchis G M, Wright P R, Michel P, Strambo D, Carrera E, Dirren E, Luft A R, Wegener S, Cereda C W, K├Ągi G, Vehoff J, Gensicke H, Lyrer P, Nedeltchev K, Khales T, Bolognese M, Salmen S, Sturzenegger R, Bonvin C, Berger C, Schelosky L, Mono M L, Rodic B, Von Reding A, Schwegler G, Tarnutzer A A, Medlin F, Humm A M, Peters N, Beyeler M, Kriemler L, Bervini D, Fandino J, Hemkens L G, Mordasini P, Arnold M, Fischer U, Bonati L H, Swiss Stroke Registry Investigators . Association of the COVID-19 outbreak with acute stroke care in Switzerland. Eur J Neurol 2021;.
   
Oechtering J, Schaedelin S, Benkert P, M├╝ller S, Achtnichts L, Vehoff J, Disanto G, Findling O, Fischer-Barnicol B, Orleth A, Chan A, Pot C, Barakovic M, Rahmanzadeh R, Galbusera R, Heijnen I, Lalive P H, Wuerfel J, Subramaniam S, Aeschbacher S, Conen D, Naegelin Y, Maceski A, Meier S, Berger K, Wiendl H, Lincke T, Lieb J, Yaldizli ├, Sinnecker T, Derfuss T, Regeniter A, Zecca C, Gobbi C, Kappos L, Granziera C, Leppert D, Kuhle J, Swiss Multiple Sclerosis Cohort Study . Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis. Ann Neurol 2021; 90:477-489.
   
Meinel T R, Branca M, De Marchis G M, Nedeltchev K, Kahles T, Bonati L, Arnold M, Heldner M R, Jung S, Carrera E, Dirren E, Michel P, Strambo D, Cereda C W, Bianco G, K├Ągi G, Vehoff J, Katan M, Bolognese M, Backhaus R, Salmen S, Albert S, Medlin F, Berger C, Schelosky L, Renaud S, Niederhauser J, Bonvin C, Schaerer M, Mono M L, Rodic B, Tarnutzer A A, Mordasini P, Gralla J, Kaesmacher J, Engelter S, Fischer U, Seiffge D J, Investigators Of The Swiss Stroke Registry . Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation. Ann Neurol 2020;.
   
Beerle N, Hader C, Kleger G R, K├Ągi G, Vehoff J. Das reversible zerebrale Vasokonstriktionssyndrom. Swiss Medical Forum 2019; 19:232-236.
   
Galovic M, Stauber A J, Leisi N, Krammer W, Brugger F, Vehoff J, Balcerak P, Mueller A, M├╝ller M, Rosenfeld J, Polymeris A, Thilemann S, De Marchis G M, Niemann T, Leifke M, Lyrer P, Saladin P, Kahles T, Nedeltchev K, Sarikaya H, Jung S, Fischer U, Manno C, Cereda C W, Sander J W, Tettenborn B, Weder B J, St├Âckli S, Arnold M, K├Ągi G. Development and Validation of a Prognostic Model of Swallowing Recovery and Enteral Tube Feeding After Ischemic Stroke. JAMA Neurol 2019; 76:561-570.
   
M├╝ller S, Vehoff J. Aktuelle Therapien der Multiplen Sklerose. der informierte @rzt 2019; Vol. 9:26-27.
   
Traenka C, Jung S, Gralla J, Kurmann R, Stippich C, Goeggel Simonetti B, Gensicke H, Mueller H, Lovblad K O, Eskandari A, Puccinelli F, Vehoff J, Weber J, Wegener S, Steiner L, K├Ągi G, Luft A, Sztajzel R, Fischer U, Bonati L H, Peters N, Michel P, Lyrer P A, Arnold M, Engelter S T. Endovascular therapy versus intravenous thrombolysis in cervical artery dissection ischemic stroke ÔÇô Results from the SWISS registry. European Stroke Journal 2018; 3:47-56.
   
Uffer D, M├╝ller S, Vehoff J. Multiple Sklerose: Neues zur monoklonalen Antik├Ârpertherapie. InFo NEUROLOGIE & PSYCHIATRIE 2018; 1:15-18.
   
Seiffge D J, K├Ągi G, Michel P, Fischer U, B├ęjot Y, Wegener S, Zedde M, Turc G, Cordonnier C, Sandor P S, Rodier G, Zini A, Cappellari M, Sch├Ądelin S, Polymeris A A, Werring D, Thilemann S, Maestrini I, Berge E, Traenka C, Vehoff J, De Marchis G M, Kapauer M, Peters N, Sirimarco G, Bonati L H, Arnold M, Lyrer P A, De Maistre E, Luft A, Tsakiris D A, Engelter S T, NOACISP Study Group . Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage. Ann Neurol 2018;.
   
Disanto G, Barro C, Benkert P, Naegelin Y, Sch├Ądelin S, Giardiello A, Zecca C, Blennow K, Zetterberg H, Leppert D, Kappos L, Gobbi C, Kuhle J, Swiss Multiple Sclerosis Cohort Study Group . Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis. Ann Neurol 2017; 81:857-870.
   
Vehoff J, Kapauer M, K├Ągi G. Akutbehandlung des isch├Ąmischen Schlaganfalls. InFo Neurologie & Psychiatrie 2017 2017; Vol.15:8-11.
   
Vehoff J, Haegele-Link S, Humm A, Mueller S K, Sauter R, Tettenborn B, Hundsberger T. Heart rate variability decreases after 3 months of sustained treatment with fingolimod. J Neurol 2017; 264:2313-2317.
   
K├Ągi G, Kapauer M, Vehoff J. Der akute Schlaganfall: Vom nicht behandelbaren Schicksal zur therapeutischen Erfolgsgeschichte. info@herz+gef├Ąss 2016; Vol. 6:20-22.
   
Pardini M, Botzkowski D, M├╝ller S, Vehoff J, Kuhle J, Ruberte E, W├╝rfel J, Gass A, Valmaggia C, Tettenborn B, Putzki N, Yaldizli ├. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography. Eur J Neurol 2016;.
   
Disanto G, Benkert P, Lorscheider J, M├╝ller S, Vehoff J, Zecca C, Ramseier S, Achtnichts L, Findling O, Nedeltchev K, Radue E W, Sprenger T, Stippich C, Derfuss T, Louvion J F, Kamm C P, Mattle H P, Lotter C, Du Pasquier R, Schluep M, Pot C, Lalive P H, Yaldizli ├, Gobbi C, Kappos L, Kuhle J, SMSC Scientific Board . The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options. PLoS One 2016; 11:e0152347.
   
Vehoff J, Tettenborn B, Mueller S. Highlights vom ECTRIMS-Kongress 2013. InFo Neurologie & Psychiatrie 2014; Ausgabe 1:42-45.
   
M├Ąhr S, Stauber A J, Vehoff J, K├Ągi G, Weber J, Tettenborn B. Akuttherapie auf der Stroke-Unit. Time is brain ÔÇô Warum rasch einweisen?. InFo Neurologie & Psychiatrie. Ausgabe 2, Seite 4-6, Februar 2014 2014; Ausgabe 2:4-6.
   
Hundsberger T, Omlin A, H├Ągele-Link S, Vehoff J, Strasser F. Autonomic Dysfunction in Cancer Cachexia Coincides With Large Fiber Polyneuropathy. J Pain Symptom Manage 2014; 48:611-618.
   
Vehoff J, Tettenborn B, K├Ągi G. Update Schlaganfall 2013. der informierte @rzt 2013; Ausgabe 11:10-13.
   
Vehoff J, M├╝ller S, Tettenborn B. Multiple Sklerose: Neue Diagnosekriterien und neue Therapiem├Âglichkeiten. InFo Neurologie & Psychiatrie 2011; Vol.9:.
   
Vehoff J, Fl├╝gel D, Tettenborn B. Iktale Asystolie. Schweiz Med Forum. 2010; 2010:194-195.
   
Vehoff J, Sch├Âtt D, Mojon D, Tettenborn B. Rethinopathy as a possible side effect in the subcutaneous treatment with interferon-beta. Schweiz Arch Neurol Psych 2008; 159 (4):.
   
Rutten B P F, Wirths O, Van De Berg W D J, Lichtenthaler S F, Vehoff J, Steinbusch H W M, Korr H, Beyreuther K, Multhaup G, Bayer T A, Schmitz C. No alterations of hippocampal neuronal number and synaptic bouton number in a transgenic mouse model expressing the beta-cleaved C-terminal APP fragment. Neurobiology of disease 2003; 12:110-20.
   
Schmitz C, Rhodes M E, Bludau M, Kaplan S, Ong P, Ueffing I, Vehoff J, Korr H, Frye C A. Depression: reduced number of granule cells in the hippocampus of female, but not male, rats due to prenatal restraint stress. Molecular psychiatry 2002; 7:810-3.
   
Vehoff J, Dafotakis M, Schmitz C, Korr H. Prenatal Programming of Depression and Schizophrenia?. Neuroembryology and Aging 2002; 1:113-127.
   
Dorin P, Zubal R, K├Ągi G, Ehl N, & Vehoff J (2022). Detection rates of atrial fibrillation by prolonged rhythm monitoring with or without preselection by biomarkers in patients with embolic strokes of undetermined source ÔÇô a single center experience. In (pp. 1): ESOC.
   
Dorin P, Von Allmen R, Hader C, & Vehoff J (2020). Surgical Treatment In Traumatic Dissection Of The Common Carotid Artery, A Case Report And Literature Review. In (pp. 1): n.a..
   
Brugger F, Weber J, K├Ągi G, & Vehoff J (2019). Retrospective comparison of the outcome of patients, treated with intravenous thrombolysis with unknown versus known symptom onset, guided by CT-imaging. In (pp. 1): keiner.
   
Velicky M, Brugger F, K├Ągi G, Weber J, & Vehoff J (2019). The impact of implementing a "fast-track" algorithm on time to treatment and outcome in patients with acute ischemic stroke due to large vessel occlusion. In (pp. 1): kein.
   
Velicky M, Brugger F, K├Ągi G, Weber J, & Vehoff J (2019). The impact of implementing a ÔÇťfast-trackÔÇŁ algorithm on time to treatment and outcome in patients with acute ischemic stroke due to large vessel occlusion. In (pp. 1): keiner.
   
Vehoff J, H├Ągele-Link S, Humm A, M├╝ller S, Sauter R, Tettenborn B, & Hundsberger T (2017). Heart rate variability decreases after 3 months of sustained treatment with fingolimod in patients with multiple sclerosis: a prospective clinical trial. In Session PRS2102 Autonomic nervous system 2 (pp. 2013): EAN.
   
Disanto G, Benkert P, Lohrscheider J, M├╝ller S, Vehoff J, Zecca C, Ramseier S, Achnichts L, Findling O, Nedeltchev K, Radue E, Sprenger T, Stippich C, Derfuss T, Louvion J F, Kamm C, Mattle H, Lotter C, Du Pasquier R, Schluepp M, Pot C, Lalive P, Kappos L, & Kuhle J (2015). The Swiss multiple sclerosis cohort study: a prospective nationwide investigation of disease evolution and the effects of new disease modifying drugs. In P775 (pp. 1): keiner.
   
Pardini M, Botzkowski D, M├╝ller S, Vehoff J, Kuhle J, Gass A, W├╝rfel J, Valmaggia C, Tettenborn B, Putzki N, & Yaldizli ├ (2015). Brain metabolites and retinal nerve fibre layer thickness and their relation to disability in multiple sclerosis: a longitudinal high-field proton magnetic resonance spectroscopy and optical coherence tomography study. In P1004 (pp. 1): kein.
   
Prochnicki A, Zieglg├Ąnsberger D, Vehoff J, M├╝ller S, Tettenborn B, & Hundsberger T (2015). Glioblastoma multiforme: Chameleon of neurology A case report. In (pp. 1).
   
D├Âhler N, M├╝ller S, Vehoff J, Galovic M, & Tettenborn B (2014). Neurocognitive changes in patients with relapsing-remitting multiple sclerosis treated with natalizumab. In P327 (pp. 1): keiner.
   
Stauber A J, Fl├╝gel D, Tettenborn B, Weber J, Rohner F, & Vehoff J (2013). Seizure induced ventricular tachycardia in structural epilepsy. In (pp. 1): keiner.
   
Zieglg├Ąnsberger D, Vehoff J, H├Ągele-Link S, & Tettenborn B (2013). Aseptische Myelitis durch Fremdk├Ârperreaktion bei intrathekalem Opioid-Katheter - 2 F├Ąlle. In (pp. 1): keiner.
   
Gegusch M, Tettenborn B, Weber J, Rohner F, & Vehoff J (2013). Coincidence of transient global amnesia and takotsubo cardiomyopathy: a case report. In (pp. 1): keiner.
   
Reker P L, Weder B, & Vehoff J (2012). Acute thrombosis of a large Developmental Venous Anomaly. In (pp. 1): SANP.
   
Reker P, Weder B, Weber J, Tettenborn B, & Vehoff J (2012). Acute thrombosis of a large Developmental Venous Anomaly. In .
   
Hundsberger T, Vehoff J, H├Ągele-Link S, Tettenborn B, & Strasser F (2011). Evaluation of the autonomic nervous system in patients with stage IV incurable, advanced solid tumours. In Clin Auton Res 2011 (pp. 21: 428 (F8)).
   
Yildiz M, M├╝ller S, Vehoff J, & Tettenborn B (2011). Multiple sclerosis associated fatigue during disease modifying treatment with natalizumab, interferon-beta and glatirameracetate: 1 year follow-up. In P03.225 (pp. 1): keiner.
   
Vehoff J, Hundsberger T, Hitz F, & Tettenborn B (2007). Neurolymphomatosis as a single sign of tumor recurrence in a patient with diffuse large B-cell lymphoma of the testis. In (pp. 34): Schweiz Arch Neurol Psychiatr;158(4):, P34.
   
Vehoff J, H├Ągele-Link S, Hundsberger T, & Tettenborn B (2011). The evaluation of the autonomic nervous system using the Finometer Pro device and sympathetic skin response (SSR): Results in 141 consecutive patients. Presented at Jahrestagung der Schweizerischen Gesellschaft f├╝r klinische Neurophysiologie (SGKN), Luzern.
   
H├Ągele-Link S, Hundsberger T, Vehoff J, & Tettenborn B (2009). Evaluation of the autonomic nervous system using the Finometer device and sympathetic skin responses (SSR).
   
Vehoff J, & M├╝ller S (2009). Spontaneous internal carotid artery dissection presenting as hypoglossal nerve palsy. Presented at Gemeinsame Jahrestagung Schweizerische Neurologische Gesellschaft SNG (182. Tagung), Interlaken.
   
Vehoff J (2008). Retinopathy as a possible side effect in the subcutaneous treatment with interferon-beta. Presented at 100 Jahre SNG Jubil├Ąumstagung Schweizerische Neurologische Gesellschaft SNG, Montreux, Schweiz.
   
Vehoff J (2007). Neurolymphomatosis as a single sign of tumour recurrence in a patient with diffuse large B-cell lymphoma of the testis. Presented at Gemeinsame Jahrestagung Schweizerische Neurologische Gesellschaft (178.Tagung), Lugano.
   
 
page 1 of 1